BSE filing, NSE: DENISCHEM. Summary written from the filing by ALFA Finder's alert engine.
Denis Chem Lab Ltd: key numbers
- Share price
- ₹61.30
- Market cap
- ₹85.06 Cr
- Revenue (annual)
- ₹181.7 Cr
- Net profit (annual)
- ₹8.41 Cr
- P/E (TTM)
- 10.7×Sector 46.1×
- Promoter holding
- 38.98%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Denis Chem Lab Ltd
All →Denis Chem Lab Board Meeting Date
Denis Chem Lab Ltd scheduled its board meeting for 4 November 2026 to approve Q1 FY27 unaudited results. Trading window remains closed until 48 hours post-declaration.
Denis Chem Lab Capital Structure Change
VS Holding BV sold 284,447 shares of Denis Chem Lab Ltd via open market transactions. Post-transaction, its shareholding stands at 14.41%.
- Execution
- September and October 2026
Denis Chem Lab Other Announcement
Denis Chem Lab Ltd has submitted its quarterly shareholding pattern for the quarter ended 30 September 2026, as per regulatory requirements.
Denis Chem Lab Management Change
Denis Chem Lab Limited shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director. His three-year term is effective from August 1, 2026.
- Execution
- 3 years
Denis Chem Lab Other Announcement
Denis Chem Lab Limited's shareholders confirmed the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors. The appointment is for a five-year term ending FY 2030-31.
- Execution
- 5 years
Denis Chem Lab Annual General Meeting
Denis Chem Lab Limited conducted its 45th Annual General Meeting on September 25, 2026. Key businesses transacted included the declaration of a Rs. 2.50 per share dividend and management re-appointments.
Other board meeting date announcements
All →Pokarna Board Meeting Date
Pokarna Ltd intimated that its Board meets on 03 Nov 2026 to consider unaudited Q1 and H1 FY27 results. The trading window stays closed till 05 Nov 2026.
Mahaveer Infoway Board Meeting Date
Mahaveer Infoway Ltd scheduled a board meeting for 3 Nov 2026 to approve Q1 FY27 unaudited results and the limited review report. This is a routine prior intimation under Reg 29(1)(a).
Indowind Energy Board Meeting Date
Indowind Energy scheduled a board meeting on 5 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-approval.
Dhunseri Ventures Board Meeting Date
Dhunseri Ventures Ltd intimated that its Board will meet on 6 November 2026, inter alia to approve Q2 FY27 results. The trading window stays closed until 8 November 2026.
CESC Board Meeting Date
CESC Ltd scheduled its Board Meeting for 5 Nov 2026 to consider Q2/H1 FY27 unaudited results. No financial figures or decisions are reported in this advance intimation.
Genpharmasec Board Meeting Date
Genpharmasec Ltd will hold a Board meeting on 03 Nov 2026. Agenda includes proposing approval of Q2/H1 FY27 unaudited results.